Functions of Tat: The versatile protein of human immunodeficiency virus type 1

Journal of General Virology

Volumn 91, Issue 1, 2010, Pages 1-12

  Romani, Bizhari ^a   Engelbrecht, Susan ^a,b   Glashoff, Richard H ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; NUCLEOCAPSID PROTEIN; PROTEIN BCL 2; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS DNA;

APOPTOSIS; CANCER INVASION; CELL TYPE; CONCENTRATION PROCESS; DEMENTIA; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREGULATION; JC VIRUS; MALIGNANT NEOPLASTIC DISEASE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION; REVIEW; RNA SYNTHESIS; TRANSACTIVATION; VIRUS CARCINOGENESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRULENCE; VIRULENCE FACTORS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 73149083473     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.016303-0     Document Type: Review

References (117)

1. Ambrosino, C., Ruocco, M. R., Chen, X., Mallardo, M., Baudi, F., Trematerra, S., Quinto, I., Venuta, S. & Scala, G. (1997). HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein β (NF-IL6) transcription factors. J Biol Chem 272, 14883-14892.
2. Ammosova, T., Berro, R., Jerebtsova, M., Jackson, A., Charles, S., Klase, Z., Southerland, W., Gordeuk, V. R., Kashanchi, F. & Nekhai, S. (2006). Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription. Retrovirology 3, 78.
3. Aoki, Y. & Tosato, G. (2004). HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood 104, 810-814.
4. Barton, C. H., Biggs, T. E., Mee, T. R. & Mann, D. A. (1996). The human immunodeficiency virus type 1 regulatory protein Tat inhibits interferon-induced iNos activity in a murine macrophage cell line. J Gen Virol 77, 1643-1647.
5. Bennasser, Y. & Bahraoui, E. (2002). HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-βII and -δ. FASEB J 16, 546-554.
6. Bennasser, Y., Yeung, M. L. & Jeang, K.-T. (2006). HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem 281, 27674-27678.
7. Bernard-Gallon, D., Bosviel, R., Delort, L., Fontana, L., Chamoux, A., Rabiau, N., Kwiatkowski, F., Chalabi, N., Satih, S. & Bignon, Y. J. (2008). DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer 7, 36.
8. Bowater, R. P., Borts, R. H. & White, M. F. (2009). DNA damage: from causes to cures. Biochem Soc Trans 37, 479-481.
9. Bres, V., Kiernan, R., Emiliani, S. & Benkirane, M. (2002). Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication. J Biol Chem 277, 22215-22221.
10. Campbell, G. R., Pasquier, E., Watkins, J., Bourgarel-Rey, V., Peyrot, V., Esquieu, D., Barbier, P., de-Mareuil, J., Braguer, D. & other authors (2004). The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J Biol Chem 279, 48197-48204.
11. Cantaluppi, V., Biancone, L., Boccellino, M., Doublier, S., Benelli, R., Carlone, S., Albini, A. & Camussi, G. (2001). HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. AIDS Res Hum Retroviruses 17, 965-976.
12. Chang, P. Y., Stellrecht, K., Melana, S. & Pogo, B. G. T. (1994). Elements in the long terminal repeat of HIV-1 that interact with nuclear extracts from Jurkat cells persistently infected with vaccinia virus. Virus Res 34, 127-138.
13. Chauhan, A., Turchan, J., Pocernich, C., Bruce-Keller, A., Roth, S., Butterfield, D. A., Major, E. O. & Nath, A. (2003). Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem 278, 13512-13519.
14. Chen, S., Chen, R., He, M., Pang, R., Tan, Z. & Yang, M. (2009). Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors. Bioorg Med Chem 17, 1948-1956.
15. Cheng, J., Nath, A., Knudsen, B., Hochman, S., Geiger, J. D., Ma, M. & Magnuson, D. S. (1998). Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience 82, 97-106.
16. D'Orso, I. & Frankel, A. D. (2009). Tat acetylation modulates assembly of a viral-host RNA-protein transcription complex. Proc Natl Acad Sci U S A 106, 3101-3106.
17. da Silva, F. H., Dalberto, T. P. & Nardi, N. B. (2006). Beyond retrovirus infection: HIV meets gene therapy. Genet Mol Biol 29, 367-379.
18. + T lymphocytes. J Immunol 181, 8460-8477.
19. Daelemans, D., Schols, D., Witvrouw, M., Pannecouque, C., Hatse, S., van-Dooren, S., Hamy, F., Klimkait, T., de-Clercq, E. & VanDamme, A. M. (2000). A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry. Mol Pharmacol 57, 116-124.
20. Dalakas, M. C. (2006). Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord 16, 223-236.
21. de Mareuil, J., Carre, M., Barbier, P., Campbell, G. R., Lancelot, S., Opi, S., Esquieu, D., Watkins, J. D., Prevot, C. & other authors (2005). HIV-1 Tat protein enhances microtubule polymerization. Retrovirology 2, 5.
22. Demarchi, F., Gutierrez, M. I. & Giacca, M. (1999). Human immunodeficiency virus type 1 Tat protein activates transcription factor NF-κB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J Virol 73, 7080-7086.
23. Deng, L., de-la-Fuente, C., Fu, P., Wang, L., Donnelly, R., Wade, J. D., Lambert, P., Li, H., Lee, C. G. & Kashanchi, F. (2000). Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277, 278-295.
24. Deng, L., Wang, D., de-la-Fuente, C., Wang, L., Li, H., Lee, C. G., Donnelly, R., Wade, J. D., Lambert, P. & Kashanchi, F. (2001). Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology 289, 312-326.
25. Deregibus, M. C., Cantaluppi, V., Doublier, S., Brizzi, M. F., Deambrosis, I., Albini, A. & Camussi, G. (2002). HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem 277, 25195-25202.
26. Drewes, G., Ebneth, A. & Mandelkow, E. M. (1998). MAPs, MARKs and microtubule dynamics. Trends Biochem Sci 23, 307-311.
27. Epie, N., Ammosova, T., Sapir, T., Voloshin, Y., Lane, W. S., Turner, W., Reiner, O. & Nekhai, S. (2005). HIV-1 Tat interacts with LIS1 protein. Retrovirology 2, 6.
28. Evans, P., Dampier, W., Ungar, L. & Tozeren, A. (2009). Prediction of HIV-1 virus-host protein interactions using virus and host sequence motifs. BMC Med Genomics 2, 27.
29. Fanales-Belasio, E., Moretti, S., Fiorelli, V., Tripiciano, A., Cossut, M. R. P., Scoglio, A., Collacchi, B., Nappi, F., Macchia, I. & other authors (2009). HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J Immunol 182, 2888-2897.
30. Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M. & Beltram, F. (2003). Caveolae-mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real time. Mol Ther 8, 284-294.
31. Fu, W., Sanders-Beer, B. E., Katz, K. S., Maglott, D. R., Pruitt, K. D. & Ptak, R. G. (2009). Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res 37, D417.
32. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K. & Sugiura, Y. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276, 5836-5840.
33. Gallo, R. C. (1999). Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine. Proc Natl Acad Sci U S A 96, 8324-8326.
34. Gandhi, N., Saiyed, Z., Thangavel, S., Rodriguez, J., Rao, K. V. K. & Nair, M. P. N. (2009). Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and anti-inflammatory cytokines by primary monocytes. AIDS Res Hum Retroviruses 25, 691-699.
35. Giacca, M. (2005). HIV-1 Tat, apoptosis and the mitochondria: a tubulin link? Retrovirology 2, 7.
36. Giunta, B., Hou, H., Zhu, Y., Rrapo, E., Tian, J., Takashi,M., Commins, D., Singer, E., He, J. & other authors (2009). HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice. Int J Clin Exp Pathol 2, 433-443.
37. Gorrill, T., Feliciano, M., Mukerjee, R., Sawaya, B. E., Khalili, K. & White, M. K. (2006). Activation of early gene transcription in polyomavirus BK by human immunodeficiency virus type 1 Tat. J Gen Virol 87, 1557-1566.
38. Gupta, S., Boppana, R., Mishra, G. C., Saha, B. & Mitra, D. (2008). HIV-1 Tat suppresses gp120-specific T cell response in IL-10- dependent manner. J Immunol 180, 79-88.
39. Harrich, D., Ulich, C., Garcia-Martinez, L. & Gaynor, R. B. (1997). Tat is required for efficient HIV-1 reverse transcription. EMBO J 16, 1224-1235.
40. Haughey, N. J. & Mattson, M. P. (2002). Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr 31, S55-S61.
41. WAF-1/CIP-1. Bioconjug Chem 17, 1280-1287.
42. Hwang, S., Tamilarasu, N., Kibler, K., Cao, H., Ali, A., Ping, Y. H., Jeang, K. T. & Rana, T. M. (2003). Discovery of a small molecule Tattrans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication. J Biol Chem 278, 39092-39103.
43. Inoue, Y., Asanuma, T., Smith, N., Saunders, D., Oblander, J., Kotake, Y., Floyd, R. A. & Towner, R. A. (2007). Modulation of Fas-FasL related apoptosis by PBN in the early phases of choline deficient diet-mediated hepatocarcinogenesis in rats. Free Radic Res 41, 972-980.
44. Ju, S. M., Song, H. Y., Lee, J. A., Lee, S. J., Choi, S. Y. & Park, J. (2009). Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-κB dependent pathway in human astrocytes. Exp Mol Med 41, 86-93.
45. Kameoka, M., Morgan, M., Binette, M., Russell, R. S., Rong, L., Guo, X., Mouland, A., Kleiman, L., Liang, C. & Wainberg, M. A. (2002). The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. J Virol 76, 3637-3645.
46. Kim, T. A., Avraham, H. K., Koh, Y. H., Jiang, S., Park, I.W. & Avraham, S. (2003). HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J Immunol 170, 2629-2637.
47. Kim, H. J., Martemyanov, K. A. & Thayer, S. A. (2008). Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J Neurosci 28, 12604-12613.
48. Klase, Z., Winograd, R., Davis, J., Carpio, L., Hildreth, R., Heydarian, M., Fu, S., McCaffrey, T., Meiri, E. & other authors (2009). HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6, 18.
49. Li, J. C. B., Lee, D. C. W., Cheung, B. K. W. & Lau, A. S. Y. (2005). Mechanisms for HIV Tat upregulation of IL-10 and other cytokine expression: kinase signaling and PKR-mediated immune response. FEBS Lett 579, 3055-3062.
50. Liang, C. & Wainberg, M. A. (2002). The role of Tat in HIV-1 replication: an activator and/or a suppressor? AIDS Rev 4, 41-49.
51. Licona-Limón, P. & Soldevila, G. (2007). The role of TGF-β superfamily during T cell development: new insights. Immunol Lett 109, 1-12.
52. Liu, Y., Jones, M., Hingtgen, C. M., Bu, G., Laribee, N., Tanzi, R. E., Moir, R. D., Nath, A. & He, J. J. (2000). Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6, 1380-1387.
53. Mahlknecht, U., Dichamp, I., Varin, A., Lint, C. V. & Herbein, G. (2008). NF-κB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. J Leukoc Biol 83, 718-727.
54. Matsui, M., Warburton, R. J., Cogswell, P. C., Baldwin, A. S. & Frelinger, J. A. (1996). Effects of HIV-1 Tat on expression of HLA class I molecules. J Acquir Immune Defic Syndr Hum Retrovirol 11, 233-240.
55. Mayol, K., Munier, S., Beck, A., Verrier, B. & Guillon, C. (2007). Design and characterization of an HIV-1 Tat mutant: inactivation of viral and cellular functions but not antigenicity. Vaccine 25, 6047-6060.
56. Melekhovets, Y., Ramezani, A., Kyriakopoulou, L. & Joshi, S. (2001). Tat-RNase H and its use in HIV gene therapy. Gene Ther Mol Biol 6, 69-77.
57. Miller, M. A., Weibel, C., Ferguson, D., Landry, M. L. & Kahn, J. S. (2009). WU polyomavirus in patients infected with HIV or hepatitis C virus, Connecticut, USA, 2007. Emerg Infect Dis, doi:10.3201/eid1507. 090150.
58. Mischiati, C., Pironi, F., Milani, D., Giacca, M.,Mirandola, P., Capitani, S. & Zauli, G. (1999). Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. AIDS 13, 1637-1645.
59. Miura, Y., Koyanagi, Y. & Mizusawa, H. (2003). TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIV-encephalopathy. J Med Dent Sci 50, 17-25.
60. Nakajima, H., Mizuta, N., Fujiwara, I., Sakaguchi, K., Ogata, H., Magae, J., Yagita, H. & Koji, T. (2008). Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 13, 1013-1021.
61. Nekhai, S., Jerebtsova, M., Jackson, A. & Southerland, W. (2007). Regulation of HIV-1 transcription by protein phosphatase 1. Curr HIV Res 5, 3-9.
62. Nunnari, G., Smith, J. A. & Daniel, R. (2008). HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? J Exp Clin Cancer Res 27, 3.
63. Nyagol, J., Leucci, E., Onnis, A., Falco, G. D., Tigli, C., Sanseverino, F., Torriccelli, M., Palummo, N., Pacenti, L. & other authors (2006). The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther 5, 684-690.
64. Ouellet, D. L., Plante, I., Landry, P., Barat, C., Janelle, M. E., Flamand, L., Tremblay, M. J. & Provost, P. (2008). Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 36, 2353-2365.
65. Pagans, S., Pedal, A., North, B. J., Kaehlcke, K., Marshall, B. L., Dorr, A., Hetzer-Egger, C., Henklein, P., Frye, R. & other authors (2005). SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 3, E41.
66. Paquette, J. C., Guerin, P. J. & Gauthier, E. R. (2005). Rapid induction of the intrinsic apoptotic pathway by L-glutamine starvation. J Cell Physiol 202, 912-921.
67. Park, I. W., Ullrich, C. K., Schoenberger, E., Ganju, R. K. & Groopman, J. E. (2001). HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J Immunol 167, 2766-2771.
68. Penza, M., Buccigrossi, V., Giannattasio, A., Marco, G. D., Esposito, C., Polito, G., Squeglia, V., Assante, L. R., Ambrosio, R. & Guarino, A. (2008). HIV-1 transactivator factor (Tat) induces damage through a redox mechanism in human intestinal epithelial cells. Dig Liver Dis 40, A97.
69. Perez-Cruz, I., Cárcamo, J. M. & Golde, D. W. (2007). Caspase-8 dependent trail-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase. Apoptosis 12, 225-234.
70. Pinney, J. W., Dickerson, J. E., Fu, W., Sanders-Beer, B. E., Ptak, R. G. & Robertson, D. L. (2009). HIV-host interactions: a map of viral perturbation of the host system. AIDS 23, 549-554.
71. Pocernich, C. B., Sultana, R., Mohmmad-Abdul, H., Nath, A. & Butterfield, D. A. (2005). HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Res Brain Res Rev 50, 14-26.
72. Poggi, A. & Zocchi, M. R. (2006). HIV-1 Tat triggers TGF-β production and NK cell apoptosis that is prevented by pertussis toxin B. Clin Dev Immunol 13, 369-372.
73. Price, T. O., Ercal, N., Nakaoke, R. & Banks, W. A. (2005). HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 1045, 57-63.
74. Ptak, R. G., Fu, W., Sanders-Beer, B. E., Dickerson, J. E., Pinney, J. W., Robertson, D. L., Rozanov, M. N., Katz, K. S., Maglott, D. R. & Pruitt, K. D. (2008). Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retroviruses 24, 1497-1502.
75. Pugliese, A., Vidotto, V., Beltramo, T., Petrini, S. & Torre, D. (2005). A review of HIV-1 Tat protein biological effects. Cell Biochem Funct 23, 223-227.
76. Pumfery, A., Deng, L., Maddukuri, A., de-la-Fuente, C., Li, H., Wade, J. D., Lambert, P., Kumar, A. & Kashanchi, F. (2003). Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 1, 343-362.
77. Ramalingam, S., Kannangai, R., Abraham, O. C., Subramanian, S., Rupali, P., Pulimood, S. A., Jesudason, M. V. & Sridharan, G. (2008). Investigation of apoptotic markers among human immunodeficiency virus (HIV-1) infected individuals. Indian J Med Res 128, 728-733.
78. Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D. & Pomerantz, R. J. (2009). The challenge of finding a cure for HIV infection. Science 323, 1304-1307.
79. Rohr, O., Marban, C., Aunis, D. & Schaeffer, E. (2003). Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J Leukoc Biol 74, 736-749.
80. Romani, B. & Engelbrecht, S. (2009). Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. J Gen Virol 90, 1795-1805.
81. Rossi, A., Mukerjee, R., Ferrante, P., Khalili, K., Amini, S. & Sawaya, B. E. (2006). Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. J Gen Virol 87, 1613-1623.
82. Ruwanpura, S. M., McLachlan, R. I., Stanton, P. G. & Meachem, S. J. (2008). Follicle-stimulating hormone affects spermatogonial survival by regulating the intrinsic apoptotic pathway in adult rats. Biol Reprod 78, 705-713.
83. Samuel, C. E. (2006). Virus-host interaction minireview series: human immunodeficiency virus, hepatitis C virus, and influenza virus. J Biol Chem 281, 8305-8307.
84. Sawaya, B. E., Khalili, K., Gordon, J., Taube, R. & Amini, S. (2000). Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem 275, 35209-35214.
85. Scala, G., Ruocco, M. R., Ambrosino, C., Mallardo, M., Giordano, V., Baldassarre, F., Dragonetti, E., Quinto, I. & Venuta, S. (1994). The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med 179, 961-971.
86. Schwarze, S. R. & Dowdy, S. F. (2000). In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21, 45-48.
87. Schwarze, S. R., Ho, A., Vocero-Akbani, A. & Dowdy, S. F. (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572.
88. Schwarze, S. R., Hurska, K. A. & Dowdy, S. F. (2000). Protein transduction: unrestricted delivery into all cells. Trends Cell Biol 10, 290-295.
89. Siegelin, M. D., Reuss, D. E., Habel, A., Rami, A. & von-Deimling, A. (2009). Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. Neuro-oncol 11, 122-131.
90. Sodhi, A., Montaner, S. & Gutkind, J. S. (2004). Viral hijacking of G-protein coupled-receptor signalling networks. Nat Rev Mol Cell Biol 5, 998-1012.
91. Stettner, M. R., Nance, J. A., Wright, C. A., Kinoshita, Y., Kim, W. K., Morgello, S., Rappaport, J., Khalili, K., Gordon, J. & Johnson, E. M. (2009). SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. J Gen Virol 90, 2005-2014.
92. Subramanian, M., Pilli, T., Bhattacharya, P., Pacini, F., Nikiforov, Y. E., Kanteti, P. V. & Prabhakar, B. S. (2009). Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis. J Clin Endocrinol Metab 94, 1467-1471.
93. Sun, Y., Huang, Y. C., Xu, Q. Z., Wang, H. P., Bai, B., Sui, J. L. & Zhou, P. K. (2006). HIV-1 Tat depresses DNA-PKCs expression and DNA repair, and sensitizes cells to ionizing radiation. Int J Radiat Oncol Biol Phys 65, 842-850.
94. Tarasenko, T., Kole, H. K., Chi, A. W., Mentink-Kane, M. M., Wynn, T. A. & Bolland, S. (2007). T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc Natl Acad Sci U S A 104, 11382-11387.
95. Tian, R.-r., Liano, Q.-J. & Chen, X. (2008). Prevention and treatment of KSHV-associated diseases with antiviral drugs. Virol Sin 23, 486-495.
96. Toda, T., Nakamura, M., Morisawa, H. & Hirota, M. (2007). Proteomic identification of oxidative-stress-reporting biomarkers differentially secreted from human neuroblastoma SH-SY5Y cells. J Electrophoresis 51, 21-26.
97. Toschi, E., Bacigalupo, I., Strippoli, R., Chiozzini, C., Cereseto, A., Falchi, M., Nappi, F., Sgadari, C., Barillari, G. & other authors (2006). HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol Biol Cell 17, 1985-1994.
98. Tournier, J. N. & Quesnel-Hellmann, A. (2006). Host-pathogen interactions: a biological rendez-vous of the infectious nonself and danger models. PLoS Pathog 2, E44.
99. Turchan, J., Pocernich, C. B., Gairola, C., Chauhan, A., Schifitto, G., Butterfield, D. A., Buch, S., Narayan, O., Sinai, A. & other authors (2003). Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60, 307-314.
100. Turner, M. A. & Palefsky, J. M. (1998). HIV-1 Tat protein increases invasion of human papillomavirus type 16 positive keratinocytes. J Acquir Immune Defic Syndr 17, A13.
101. Turpin, J. A. (2003). The next generation of HIV/AIDS drugs: novel and developmental anti HIV drugs and targets. Expert Rev Anti Infect Ther 1, 97-128.
102. Tyagi, M., Rusnati, M., Presta, M. & Giacca, M. (2001). Internalization of HIV-1 Tat requires cell surface heparin sulfate proteoglycans. J Biol Chem 276, 3254-3261.
103. Vashistha, H., Husain, M., Kumar, D. & Singhal, P. C. (2009). Tubular cell HIV-1 gp120 expression induces caspase 8 activation and apoptosis. Ren Fail 31, 303-312.
104. Vendeville, A., Rayne, F., Bonhoure, A., Bettache, N., Montcourrier, P. & Beaumelle, B. (2004). HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol Biol Cell 15, 2347-2360.
105. Wallace, D. R., Dodson, S. L., Nath, A. & Booze, R. M. (2005). Delta opioid agonists attenuate TAT1-72-induced oxidative stress in SK-NSH cells. Neurotoxicology 27, 101-107.
106. Westendorp, M. O., Li-Weber, M., Frank, R. W. & Krammeri, P. H. (1994). Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 68, 4177-4185.
107. Williams, S. A., Chen, L. F., Kwon, H., Ruiz-Jarabo, C. M., Verdin, E. & Greene, W. C. (2006). NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J 25, 139-149.
108. Wong, K., Sharma, A., Awasthi, S., Matlock, E. F., Rogers, L., Lint, C. V., Skiest, D. J., Burns, D. K. & Harrod, R. (2005). HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB. J Biol Chem 280, 9390-9399.
109. Yedavalli, V. S. R. K., Benkirane, M. & Jeang, K. T. (2003). Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1. J Biol Chem 278, 6404-6410.
110. Zagury, D., Lachgar, A., Chams, V., Fall, L. S., Bernard, J., Zagury, J. F., Bizzini, B., Gringeri, A., Santagostini, E. & other authors (1998). Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A 95, 3851-3856.
111. Zauli, G.,Milani, D.,Mirandola, P.,Mazzoni, M., Secchiero, P., Miscia, S. & Capitani, S. (2001). HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway. FASEB J 15, 483-491.
112. Zhang, M., Li, X., Pang, X., Ding, L., Wood, O., Clouse, K. A., Hewlett, I. & Dayton, A. I. (2002). Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. J Biomed Sci 9, 133-139.
113. Zhao, T., Adams, M. H., Zou, S. P., El-Hage, N., Hauser, K. F. & Knapp, P. E. (2007). Silencing the PTEN gene is protective against neuronal death induced by human immunodeficiency virus type 1 Tat. J Neurovirol 13, 97-106.
114. Zheng, L., Yang, Y. D., Lu, G. C. & Salvato, M. S. (2005). Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes. J Zhejiang Univ Sci B 6, 668-672.
115. Zheng, L., Yang, Y., Guocai, L., Pauza, C. D. & Salvato, M. S. (2007). HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand. Intervirology 50, 224-228.
116. Zhou,M., Deng, L., Kashanchi, F., Brady, J. N., Shatkin, A. J. & Kumar, A. (2003). The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA. Proc Natl Acad Sci U S A 100, 12666-12671.
117. Zuo, Y., Matsusaka, T., Zhong, J., Ma, J., Ma, L. J., Hanna, Z., Jolicoeur, P., Fogo, A. B. & Ichikawa, I. (2006). HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol 17, 2832-2843.